Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
152922-73-1COC(=O)CC1(CS)CC1JRHLVNAWLWIHDN-UHFFFAOYSA-NSicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
VerwendenMethyl 1-(Mercaptomethyl)cyclopropaneacetate is an important organic synthetic material for the preparation of novel salt-type URAT-1 inhibitors. It is also an intermediate for montelukast, an orally administered, highly potent, selective leukotriene receptor antagonist approved for the treatment of asthma and allergic rhinitis.
Wird geladen…
152922-73-1DTXSID801192074